Andrew D'SilvaB. Riley FBR
Dana FlandersGuggenheim Securities
Yi ChenH.C. Wainwright
EyePoint Pharmaceuticals is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding EyePoint Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of EyePoint Pharmaceuticals or its management. EyePoint Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.